Table 2.
Female | Male | All | |||||||
---|---|---|---|---|---|---|---|---|---|
Independent Variables | HR | 95% CI | P-value | HR | 95% CI | P-value | HR | 95% CI | P-value |
Baseline status: Nontoxigenic C. difficile compared to no C. difficile |
5.13 | 1.47, 17.83 | 0.010 | 0.44 | 0.04, 4.43 | 0.482 | 1.92 | 0.68, 5.46 | 0.221 |
Covariates: | |||||||||
Age | 1.00 | 0.97, 1.03 | 0.926 | 1.04 | 0.99, 1.08 | 0.100 | 1.02 | 0.99, 1.04 | 0.229 |
Female | _ | _ | _ | _ | _ | _ | 1.10 | 0.47, 2.57 | 0.833 |
Non-White | 0.89 | 0.19, 4.23 | 0.884 | 2.93 | 0.73, 11.77 | 0.130 | 1.63 | 0.59, 4.48 | 0.346 |
Nursing home, previous | 11.42 | 1.08, 121.07 | 0.043 | 3.97 | 0.34, 46.57 | 0.273 | 3.89 | 0.78, 19.43 | 0.098 |
Charlson Deyo score | 1.11 | 0.8, 1.54 | 0.512 | 1.06 | 0.73, 1.52 | 0.769 | 1.11 | 0.89, 1.40 | 0.357 |
Number admissions during previous 28 days | 0.47 | 0.07, 3.06 | 0.429 | 1.43 | 0.3, 6.54 | 0.645 | 0.88 | 0.29, 2.68 | 0.816 |
Number nights in hospital during previous 180 days | 0.99 | 0.95, 1.03 | 0.560 | 0.99 | 0.94, 1.04 | 0.633 | 0.99 | 0.95, 1.02 | 0.422 |
Number prior positive C. difficile tests | 1.31 | 0.15, 11.58 | 0.809 | 1.48 | 0.65, 3.39 | 0.352 | 1.25 | 0.54, 2.91 | 0.602 |